Optimisation of itraconazole therapy using target drug concentrations

JM Poirier, G Cheymol - Clinical pharmacokinetics, 1998 - Springer
Poirier JM, Cheymol G. A rapid and specific liquid chromatographic assay for the determination
of itraconazole and hydroxyitraconazole in plasma. Ther Drug Monit 1997; 19: 247-8 …

Youth with disabilities in juvenile corrections: A national survey

…, PE Leone, DM Osher, JM Poirier - Exceptional …, 2005 - journals.sagepub.com
Improving our knowledge of the number of incarcerated youth with disabilities can assist
educators, other professionals, and policymakers to develop more effective services for youth. …

An examination of school climate in effective alternative programs

MM Quinn, JM Poirier, SE Faller, RA Gable… - … for Children and …, 2006 - Taylor & Francis
The alternative education field lacks a common definition and has a major divide between
the differing philosophies of alternative programs; little empirical evidence is available to …

[HTML][HTML] 3-Dimensional porous nanocomposite scaffolds based on cellulose nanofibers for cartilage tissue engineering: tailoring of porosity and mechanical …

N Naseri, JM Poirier, L Girandon, M Fröhlich… - RSC …, 2016 - pubs.rsc.org
Fully bio-based 3-dimensional porous scaffolds based on freeze-dried cellulose nanofibers (70–90
wt%) stabilized using a genipin crosslinked matrix of gelatin and chitosan were …

Study of Effective Alternative Education Programs: Final Grant Report.

MM Quinn, JM Poirier - American Institutes for Research, 2007 - ERIC
This report presents findings of a study conducted to identify the components of systems that
effectively meet the diverse, ever changing needs of children with disabilities for whom …

The road to the STEM professoriate for underrepresented minorities: A review of the literature

JM Poirier, C Tanenbaum, C Storey… - … American Institutes for …, 2009 - voced.edu.au
The National Science Foundation's [NSF's] Alliances for Graduate Education and the
Professoriate (AGEP) program is specifically designed to address obstacles and increase the …

Pharmacokinetics of β‐adrenoceptor blockers in obese and normal volunteers

G Cheymol, JM Poirier, PA Carrupt… - British journal of …, 1997 - Wiley Online Library
Aims Obesity can modify the pharmacokinetics of lipophilic drugs. As β‐adrenoceptor blockers
(BB) are often prescribed for obese patients suffering from hypertension or coronary heart …

Pharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjects

…, JPL Moing, L Naditch, JC Levron, JM Poirier - European journal of …, 1997 - Springer
Objective: The pharmacokinetics of a single iv dose of the new racemic β-adrenoceptor-blocker
nebivolol [0.073 mg base · kg –1 ideal body weight (IBW)] was studied in 9 obese (157% …

[BOOK][B] Educational equity and public policy: Comparing results from 16 countries

JD Sherman, JM Poirier - 2007 - Citeseer
The right to education has been recognised by the international community for the last half
century and has led to increasing interest in the equity of countries’ education systems. …

Atazanavir urinary stones in an HIV-infected patient

J Pacanowski, JM Poirier, I Petit, JL Meynard… - Aids, 2006 - journals.lww.com
A 56-year-old man with HIV infection (CD4 cell count 494 cells/ml, HIV RNA load 64 800
copies/ml) initiated a regimen of atazanavir–ritonavir (300/100mg), tenofovir, abacavir and …